Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
PreveCeutical Medical Inc. (PRVCF) had Free Cash Flow per Share of $-0.00 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-0.86M |
|
-- |
|
-- |
|
$0.59M |
|
$-0.59M |
|
$-0.26M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.59M |
|
$-0.59M |
|
536.11M |
|
536.11M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.09M |
|
$0.00M |
|
$0.08M |
|
$0.16M |
|
$4.96M |
|
$0.05M |
|
$0.05M |
|
$5.01M |
|
$-4.84M |
|
$-4.92M |
|
$-4.84M |
|
543.70M |
|
| Cash Flow Statement Financials | |
$-0.31M |
|
$-0.00M |
|
$0.36M |
|
$0.00M |
|
$0.04M |
|
$0.04M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.01 |
|
-0.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.70% |
|
17.42% |
|
-520.55% |
|
17.87% |
|
$-0.01 |
|
|
Free Cash Flow per Share |
$-0.00 |
$-0.00 |
|